Atlas FDA

BIORA EMDOGAIN(R)

FDA premarket approval P930021/S033 · decided 2025-06-10

Approval details

PMA number
P930021
Supplement
S033
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
BIORA EMDOGAIN(R)
Generic name
Biologic material, dental
Applicant
The Straumann Company
Date received
2025-03-12
Decision date
2025-06-10
Days to decision
90 days
Decision code
APPR
Product code
NQA
Advisory committee
Dental
Expedited review
No
Location
Andover, MA
Statement
addition of an alternative application needle (cannula) design for all Emdogain® packaging configurations.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.